Artivion, based in Kennesaw, Georgia, develops solutions for aortic diseases, employing 1,500 staff and offering medical devices like stent grafts and surgical sealants, along with preservation services for human tissues. Their product families include aortic stent grafts, On-X mechanical heart valves, and BioGlue Surgical Adhesive.
Artivion (AORT) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Artivion's actual EPS was -$0.01, beating the estimate of -$0.12 per share, resulting in a 91.71% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
